BIOVECTRA
LIVE

Serial Number

99479274

Owner

Agilent Technologies, Inc.

Attorney

Andrew Roppel

Filing Date

Nov 4, 2025

Add to watchlist:

No watchlists yet
View on USPTO

BIOVECTRA Trademark

Serial Number: 99479274

BIOVECTRA is a trademark filed by Agilent Technologies, Inc. on November 4, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Agilent Technologies, Inc. (4 trademarks)

5301 Stevens Creek Boulevard
Santa Clara, CA 95051

Entity Type: 03

Trademark Details

Filing Date

November 4, 2025

Registration Date

Not Registered

Published for Opposition

June 23, 2026

Goods & Services

Development of chemical additives, reagents, pharmaceutical additives, pharmaceuticals, biopharmaceuticals, medicines, medicaments for others; Research in the field of biopharmaceuticals and pharmaceuticals; Engineering services; Laboratory services using fermentation for biomanufacturing; Biochemical research and analysis; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of biopharmaceuticals and pharmaceuticals

Chemical compositions, reagents, chemical additives, and biochemical preparations for use in the manufacture of pharmaceuticals and biopharmaceuticals; Chemical compositions, reagents, chemical additives, and biochemical preparations, all for scientific research use in the fields of pharmaceuticals and biopharmaceuticals

Custom manufacturing in the field of biopharmaceuticals and pharmaceuticals, namely, chemical additives and reagents; Manufacturing process consulting; Providing technical information in the field of pharmaceutical manufacturing; Custom manufacturing of chemical additives, reagents, pharmaceutical additives, pharmaceuticals, biopharmaceuticals, medicines, and medicaments for others

Chemical reagents for pharmaceutical purposes; Chemical reagents for medical purposes; Biological reagents for medical purposes; Diagnostic reagents for medical use

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 23, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 23, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 13, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 13, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 13, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 11, 2026 GNFN
FINAL REFUSAL E-MAILED
May 11, 2026 GNFR
FINAL REFUSAL WRITTEN
May 11, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 7, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 7, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 7, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 15, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 15, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 15, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 13, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 12, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Nov 4, 2025 MAFR
NEW APPLICATION ENTERED
Nov 4, 2025 NWAP